Payment overview · 2025
General Payments
$155.25
3 reported records · 3 companies
Healthcare provider profile · identity verified
William Douglas Perry, MD
Allopathic & Osteopathic Physicians|Family Medicine · WALNUT GROVE, MS · NPI 1033196977
Verified facts
What the public records show
CMS Open Payments records show William Douglas Perry, MD received $155.25 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 78.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 96 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $121.98 | 78.6% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $17.07 | 11.0% | 1 | 2025 |
| ANI Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.20 | 10.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $155.25 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $121.98 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.07 | 1 | 2025 |
Source payment records
|
|||||
| PURIFIED CORTROPHIN GEL Normalized: purified cortrophin gel |
Drug | ANI Pharmaceuticals, Inc. | $16.20 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 96 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
96 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 1084 | 157 |
| Amlodipine Besylate | Amlodipine Besylate | 699 | 139 |
| Atorvastatin Calcium | Atorvastatin Calcium | 694 | 126 |
| Levothyroxine Sodium | Levothyroxine Sodium | 650 | 87 |
| Eliquis | Apixaban | 602 | 52 |
| Furosemide | Furosemide | 546 | 88 |
| Donepezil Hcl | Donepezil Hcl | 517 | 70 |
| Potassium Chloride | Potassium Chloride | 471 | 86 |
| Pantoprazole Sodium | Pantoprazole Sodium | 451 | 81 |
| Sertraline Hcl | Sertraline Hcl | 444 | 75 |
| Memantine Hcl | Memantine Hcl | 388 | 40 |
| Omeprazole | Omeprazole | 382 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 350 | 63 |
| Montelukast Sodium | Montelukast Sodium | 350 | 61 |
| Carvedilol | Carvedilol | 321 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 319 | 54 |
| Mirtazapine | Mirtazapine | 312 | 42 |
| Metformin Hcl | Metformin Hcl | 299 | 58 |
| Famotidine | Famotidine | 298 | 61 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 274 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 269 | 47 |
| Quetiapine Fumarate | Quetiapine Fumarate | 248 | 30 |
| Lisinopril | Lisinopril | 237 | 49 |
| Trazodone Hcl | Trazodone Hcl | 221 | 31 |
| Jardiance | Empagliflozin | 207 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 204 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 199 | 38 |
| Meloxicam | Meloxicam | 197 | 43 |
| Myrbetriq | Mirabegron | 191 | 13 |
| Losartan Potassium | Losartan Potassium | 167 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 166 | 32 |
| Levetiracetam | Levetiracetam | 162 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 162 | 31 |
| Glimepiride | Glimepiride | 158 | 34 |
| Buspirone Hcl | Buspirone Hcl | 153 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 151 | 22 |
| Prednisone | Prednisone | 151 | 61 |
| Escitalopram Oxalate | Escitalopram Oxalate | 140 | 20 |
| Olanzapine | Olanzapine | 140 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 133 | 44 |
| Risperidone | Risperidone | 128 | 15 |
| Meclizine Hcl | Meclizine Hcl | 124 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 121 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 118 | 19 |
| Entresto | Sacubitril/Valsartan | 115 | 13 |
| Allopurinol | Allopurinol | 111 | 25 |
| Amitriptyline Hcl | Amitriptyline Hcl | 111 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 111 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 109 | 30 |
| Tresiba Flextouch U-100 | Insulin Degludec | 108 | 19 |
| Pregabalin | Pregabalin | 105 | 17 |
| Baclofen | Baclofen | 104 | 14 |
| Spironolactone | Spironolactone | 103 | 23 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 99 | 18 |
| Tramadol Hcl | Tramadol Hcl | 99 | 16 |
| Divalproex Sodium | Divalproex Sodium | 97 | 13 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 97 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 96 | 30 |
| Ozempic | Semaglutide | 96 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 92 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 91 | 38 |
| Clonazepam | Clonazepam | 90 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 90 | 71 |
| Ropinirole Hcl | Ropinirole Hcl | 89 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 84 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 83 | suppressed |
| Xarelto | Rivaroxaban | 83 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 76 | 20 |
| Lactulose | Lactulose | 75 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 75 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 74 | 15 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 73 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 73 | 14 |
| Alprazolam | Alprazolam | 72 | 11 |
| Atenolol | Atenolol | 70 | 12 |
| Digoxin | Digoxin | 70 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 69 | suppressed |
| Bupropion Xl | Bupropion Hcl | 68 | suppressed |
| Sucralfate | Sucralfate | 67 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 66 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | suppressed |
| Dutasteride | Dutasteride | 64 | 12 |
| Warfarin Sodium | Warfarin Sodium | 62 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 56 | 41 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 55 | 11 |
| Nystatin | Nystatin | 55 | 25 |
| Ondansetron Odt | Ondansetron | 54 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 53 | 23 |
| Tresiba Flextouch U-200 | Insulin Degludec | 52 | 11 |
| Methocarbamol | Methocarbamol | 49 | 15 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 49 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 48 | suppressed |
| Trulicity | Dulaglutide | 48 | suppressed |
| Januvia | Sitagliptin Phosphate | 47 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 47 | suppressed |
| Colchicine | Colchicine | 44 | suppressed |
| Azithromycin | Azithromycin | 43 | 39 |
| Ipratropium Bromide | Ipratropium Bromide | 43 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 42 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 42 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 42 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 41 | suppressed |
| Finasteride | Finasteride | 40 | suppressed |
| Latanoprost | Latanoprost | 40 | suppressed |
| Mupirocin | Mupirocin | 40 | 22 |
| Novolog | Insulin Aspart | 39 | suppressed |
| Linzess | Linaclotide | 37 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 35 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 35 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 35 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 35 | 34 |
| Simvastatin | Simvastatin | 35 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 34 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 34 | suppressed |
| Celecoxib | Celecoxib | 33 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 24 |
| Fluconazole | Fluconazole | 33 | 26 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 33 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 32 | suppressed |
| Brilinta | Ticagrelor | 32 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 31 | suppressed |
| Ezetimibe | Ezetimibe | 31 | suppressed |
| Levofloxacin | Levofloxacin | 31 | 27 |
| Primidone | Primidone | 31 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 30 | suppressed |
| Novolin R | Insulin Regular, Human | 30 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 29 | 15 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 29 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 29 | suppressed |
| Topiramate | Topiramate | 29 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 23 |
| Clindamycin Hcl | Clindamycin Hcl | 28 | 16 |
| Diltiazem 24hr Er | Diltiazem Hcl | 28 | suppressed |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 19 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 27 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 26 | suppressed |
| Klor-Con 8 | Potassium Chloride | 26 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 26 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 26 | suppressed |
| Cephalexin | Cephalexin | 24 | 20 |
| Methenamine Hippurate | Methenamine Hippurate | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 19 |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 22 | 22 |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 15 |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Lovastatin | Lovastatin | 21 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Chlordiazepoxide-Clidinium | Chlordiazepoxide/Clidinium Br | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Desloratadine | Desloratadine | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | 11 |
| Clonidine | Clonidine | 12 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 12 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 12 | suppressed |
| Lotrel | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 12 | 11 |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Budesonide | Budesonide | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Lyrica | Pregabalin | 11 | suppressed |
| Ursodiol | Ursodiol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $155.25 · 3 records | Novo Nordisk Inc | CAPLYTA, Ozempic, PURIFIED CORTROPHIN GEL | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error